Timothy H. Holtz, MD, MPH, FACP, is a public health specialist, an assistant professor at the Rollins School of Public Health at Emory University, and an internationally recognized expert in global health. He co-teaches courses in tuberculosis and health and human rights, in addition to leading an elective for medical students in human rights and social medicine at the Emory University School of Medicine. Dr. Holtz trained in primary care medicine at Harvard University/Cambridge Hospital, Cambridge, Massachusetts, after which he worked with the Tibetan Government-in-Exile in the Indian Himalaya while on a Health and Human Rights fellowship from the Columbia University College of Physicians and Surgeons. He is board certified in internal medicine as well as preventive medicine, and was elected a Fellow in the American College of Physicians in 2003.

Following training at Johns Hopkins University, Harvard University, and Columbia University, Dr. Holtz became a founding member of Doctors for Global Health (DGH), a non-governmental organization with health and social justice projects in Central America, South America, and Africa. The core principles of DGH, firmly rooted in social justice and human rights, are to deliver quality medical care and to foster social rights among impoverished and marginalized communities. Along with Drs. Anne-Emanuelle Birn and Yogan Pillay, Dr. Holtz is a co-editor of the 3rd edition of the Oxford University Press Textbook of International Health, by Paul Basch.

Dr. Holtz is currently a medical epidemiologist with the International Research and Programs Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention (CDC) in Atlanta, and serves as a Captain in the U.S. Public Health Service. Dr. Holtz entered CDC in 1999 as part of the Epidemic Intelligence Service, serving as a medical officer in the agency’s malaria epidemiology branch. He also completed a preventive medicine residency through CDC, during which time he was intensely involved with the CDC response to the World Trade Center disaster and the anthrax attacks in 2001. Since 2002, Dr. Holtz has worked in Southern Africa, Eastern Europe, Southeast Asia, and South America on multidrug-resistant tuberculosis (MDR TB) control and TB/HIV program capacity building. Dr. Holtz was part of a team of scientists to recognize the emerging threat of anti-TB drug resistance, and his analysis has been critical to establishing the evidence base for the description of extensively drug-resistant tuberculosis (XDR TB). He is currently working with several governments in sub-Saharan Africa to evaluate the extent of anti-TB drug resistance in the continent, and to formulate policies to address tuberculosis and HIV/AIDS. Dr. Holtz has served as a consultant to the World Health Organization, and currently is CDC’s representative to the STOP TB Partnership’s Green Light Committee which provides access to concessionary-priced drugs for MDR/XDR TB treatment to national TB programs.